Bloomberg News and Videos — Page 18

Joe Feldman, senior research analyst and assistant director of research at Telsey, says there is a "strong signal that the turnaround is working" at Target. The retailer lifted its full-year guidance after results outpaced estimates in the second-quarter.

Betterment CEO Sarah Levy sounds the alarm on Gen Z treating sports betting like investing. She joins Open Interest to explain why gambling apps, social-media financial advice and speculative trading are blurring the line between entertainment and long-term wealth building and why investors need stronger guardrails.

Target's turnaround may finally be working. Telsey Advisory Group Senior Managing Director and Assistant Director of Research Joseph Feldman joined Bloomberg Open Interest to break down why stronger traffic, sharper merchandising and a revamped food strategy are bringing shoppers back, even without tariff refunds. He also explains why Target shouldn't copy Walmart and which struggling retailers could lose the most market share.

Shares of Moderna and Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising results when it comes to fighting skin cancer. A late-stage trial showed that the mRNA vaccine helped reduce the recurrence of melanoma. Sam Fazeli of Bloomberg Intelligence has more.

Keith Lerner, CIO & Chief Market Strategist at Truist, joins Bloomberg's Vonnie Quinn on "Bloomberg Brief" to discuss market expectations beyond the recent jitters amid a historic earnings season.

SK Hynix shares surged following the announcement of a nearly $30 billion share buyback program. Bloomberg's Ed Ludlow explains that the buyback aims to stabilize the stock after significant volatility, with shares having risen sharply in previous years but declining since June.

Gennadiy Goldberg, TD Securities head of US rates strategy, says interest rate hikes by the Federal Reserve could help flatten the yield curve. But he believes the Fed is going to try and hold rates steady. He speaks on "Bloomberg Surveillance."

Merck and Moderna announced positive results from a large late-stage trial of their personalized mRNA cancer vaccine, which significantly reduced the recurrence of melanoma, the deadliest form of skin cancer. Madison Muller reports on "Bloomberg Open Interest."

James Bullard, former president of the St. Louis Fed and dean of Purdue's Mitch Daniels School of Business, says raising interest rates in September isn't too bad of an idea for the Federal Reserve. He speaks on "Bloomberg Surveillance."

The US Department of the Treasury announced it will at least double the maximum size of its liquidity support buyback operations for longer-dated nominal coupon securities to at least $4 billion per operation, effective September 9, 2026. Michael McKee reports on Bloomberg Television.